The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.

@article{Gontero2010TheRO,
  title={The role of bacillus Calmette-Gu{\'e}rin in the treatment of non-muscle-invasive bladder cancer.},
  author={Paolo Gontero and Andreas Bohle and P. U. Malmstrom and Michael A. O'Donnell and Marco Oderda and Richard Sylvester and F. W. Witjes},
  journal={European urology},
  year={2010},
  volume={57 3},
  pages={
          410-29
        }
}
CONTEXT Bacillus Calmette-Guérin (BCG) remains the most effective intravesical treatment for non-muscle-invasive bladder cancer (NMIBC), but the clinical development of BCG has been accompanied by controversy. Recent publications have called into question a number of aspects related to its use. OBJECTIVE To review the current clinical role of BCG in NMIBC, focusing on efficacy and tolerability as primary objectives and on strategies to predict response and decrease toxicity as secondary… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 58 CITATIONS

Compared Efficacy of Intravesical Bcg Vs Mitomycin-C , and Other Dual Therapies in Non-Muscle Invasive Bladder Cancer

CA Verdeja-Robles, O Turcio-Aceves, +3 authors AY Martínez-Gómez
  • 2018
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Aspects of treatment of non-muscle invasive bladder cancer

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 10 Highly Influenced Citations

  • Averaged 3 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 94 REFERENCES

Similar Papers

Loading similar papers…